Conferences
29 June–3 July 2024, Boston, MA, USA
International Symposium on EBV & KSHV & Related Agents & Diseases—3rd Joint Meeting
This joint meeting will bring together researchers studying the oncogenic gamma-herpesviruses EBV and KSHV, as well as related agents, including murine gammaherpesvirus-68. Sessions will highlight viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection and autoimmunity, epidemiology, vaccine development, and therapeutic intervention.
The EBV/KSHV 2024 scientific advisory board (SAB) will formulate an innovative and thematic format for the meeting. The meeting encourages the presentation of data before publication to enable open discussion and feedback from a field of experts, in addition to fostering the development of their scientific communication skills. Networking opportunities will be structured for trainees to interact with senior faculty at academic institutions and scientists from industry and government. Senior scientists, clinicians, and trainees at all levels are invited to participate and attend as well as attendees with knowledge and interests outside the EBV/KSHV community to bring perspective and instructive comparisons. As a means to feature the most up-to-date and exciting unpublished research, more than 95% of the speakers will be selected based on the merits of submitted abstracts.
To find out more information about the conference, please visit the following website:
